KN
K Nityananda Reddy
Executive
Other
Browse the complete record of transactions filed by K Nityananda Reddy, Executive. Officer active across 1 company, notably Aurobindo Pharma Limited. Cumulatively, 13 reports have been logged. Activity tracked since 25 June 2021. The latest transaction was filed on 14 September 2023 (Pledge). Regulator: SEBI (PIT + SAST). All data is openly available.
Companies and markets linked to K Nityananda Reddy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
1,000,000 shares@ ₹895.758.2% of flowEquity SharesSEBI:b9ef4693a92eaa6eed800c4cb7df8410e28c75d8
2,000,000 shares@ ₹825.5514.9% of flowEquity SharesSEBI:e5f6fd6d165ff9ab14271d5e4fd1be213e9a1667
3,000,000 shares@ ₹588.1015.8% of flowEquity SharesSEBI:f326a117572ea304ee90c16647f0dc663b6f3139
845,000 shares@ ₹587.354.4% of flowEquity SharesSEBI:598b0f5053e5327be034c99c5bb925a12ffab3d7
1,000,000 shares@ ₹533.455.4% of flowEquity SharesSEBI:a8a18ea7d8bac702897f339ea2424809af589d2a
2,050,000 shares@ ₹556.9511.3% of flowEquity SharesSEBI:124bc4849919ef838f1fb894cfb8ea75eee76086
1,700,000 shares@ ₹513.108.5% of flowEquity SharesSEBI:b7a232552b1e795a99764088621a3d8a0af8c3cf
400,000 shares@ ₹522.852.1% of flowEquity SharesSEBI:286a94fe16331946ef406ed3c2e345fa335aca1d
700,000 shares@ ₹612.954.3% of flowEquity SharesSEBI:e3dd3003e6ffa7586b36533fc56f8834fd3d2788
545,000 shares@ ₹682.950.0006% mcap13.7% of flowEquity SharesSEBI:adcc5993b79089ae7b64e901d7791cef1c6b7791
300,000 shares@ ₹681.100.0003% mcap7.5% of flowEquity SharesSEBI:6590c40d35205b06a1d9f64de6f97d33468ba077
1,500,000 shares@ ₹1,002.600.0025% mcap54.7% of flowEquity SharesSEBI:b5b03421f3c5e403bd2bc475bb0df94b15f0e00a
700,000 shares@ ₹950.350.0011% mcap24.1% of flowEquity SharesSEBI:d9fe7f1167c88129b14933c69c7d3b633ed5bf4e
About K Nityananda Reddy
K Nityananda Reddy is an executive at Aurobindo Pharma Limited. He plays a crucial role in the management and strategy of the company, which is a major player in the pharmaceutical sector.